Surgalign Holdings's revenue for the
three
months ended in Mar. 2023 was $16.75 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2023 was $78.12 Mil.
Surgalign Holdings's Revenue per Share for the
three
months ended in Mar. 2023 was $1.26.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 was $10.23.
Warning Sign:
Surgalign Holdings Inc revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Surgalign Holdings was -40.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 98.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 46.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 8.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Surgalign Holdings's highest 3-Year average Revenue per Share Growth Rate was 145.40% per year. The lowest was -34.00% per year. And the median was 1.90% per year.
Surgalign Holdings Revenue Historical Data
The historical data trend for Surgalign Holdings's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Surgalign Holdings's Revenue
For the Medical Devices subindustry, Surgalign Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgalign Holdings's Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surgalign Holdings's Revenue distribution charts can be found below:
* The bar in red indicates where Surgalign Holdings's Revenue falls into.
Surgalign Holdings Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $78.12 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Surgalign Holdings Revenue Related Terms
Thank you for viewing the detailed overview of Surgalign Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Surgalign Holdings (Surgalign Holdings) Business Description
Surgalign Holdings Inc is a global medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company continues to invest in clinically validated innovation to deliver the Best surgical outcomes and improve patient's lives. It markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. The U.S. market accounts for the vast majority of revenue. It has commercial and design centers in San Diego, California, and Wurmlingen, Germany.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SRGAQ has been successfully added to your 